CTOs on the Move


 
XTuit Pharmaceuticals, Inc. is a biopharmaceutical company developing novel microenvironment-activated therapeutics targeting key mechanisms resulting in hypoxia, decreased drug uptake, drug resistance, and decreased immune response. The Company’s proprietary drug development pipeline and integrated, sophisticated clinical biomarker platform will be used for accelerated clinical development across selected cancers and fibrotic disorders. XTuit’s compounds act through pleiotropic mechanisms to inhibit extracellular matrix synthesis and stabilization, and to silence activated stromal cells, including cancer-associated fibroblasts and stellate cells. As a result, XTuit compounds alleviate hypoxia and enable enhanced drug uptake through solid stress reduction. Moreover, the drugs have been shown to down-regulate ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.xtuit.com
  • Lab Central 700 Main Street
    Cambridge, MA USA 01239
  • Phone: 781.290.0770

Executives

Name Title Contact Details

Funding

XTuit raised $22M on 06/11/2015

Similar Companies

Banziger Systems

Banziger Systems is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novartis

5764914 Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.

Distalmotion

Establishing a new standard of care, where all patients in general surgery, gynecology and urology have access to optimal minimally invasive care.

Pfizer

06795 Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City.

CHEMINPHARMA

CHEMINPHARMA is a Farmington, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.